Richard Gervasoni, MD

Original Contribution

Decrease of Vascular and Bleeding Complications After Balloon Aortic Valvuloplasty Performed Without Heparin

09/27/2014

Jean-Christophe Macia , MD;

Richard Gervasoni , MD;

Francois Roubille , MD, PhD;

Florence Leclercq , MD, PhD;

Delphine Delseny , MD;

Erika Nogue , MSc;

Valérie Macioce , MD;

Nicolas Nagot , MD, PhD;

The risk of bleeding is of major concern after percutaneous balloon aortic valvuloplasty (BAV) performed in elderly patients. In this registry, we report the effect of heparin use on rate of all severe vascular complications, bleeding,...

The risk of bleeding is of major...

09/27/2014

Journal of Invasive Cardiology

Original Contribution

Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients

07/15/2018

Pierre Robert , MD;

Patrick Messner-Pellenc , MD, PhD;

Florence Leclercq , MD, PhD;

Guillaume Cayla , MD, PhD;

Benoit Lattuca , MD;

David Belardi , MD;

Christophe Demattei , MD;

Laurent Schmutz , MD;

Luc Cornillet , MD;

Bertrand Ledermann , MD;

Jean-Christophe Macia , MD;

A. Lemmi , MD;

Richard Gervasoni , MD;

Francois Roubille , MD, PhD;

Thien Tri Cung , MD;

Recent studies have challenged systematic pretreatment with a P2Y12 inhibitor before PCI in elective and NSTEMI patients. This study assesses outcomes after performing PCI immediately after coronary angiography with an exclusive...

Recent studies have challenged...

07/15/2018

Journal of Invasive Cardiology